Karo hires GSK Consumer Healthcare’s Hale
Premium
9 September 2021
Karo Pharma has hired GlaxoSmithKline (GSK) Consumer Healthcare’s Anna Hale as chief marketing officer.
Industry News - Tag: GlaxoSmithKline
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
Karo hires GSK Consumer Healthcare’s Hale
GSK is “catching up” in VMS e-commerce
Premium
2 August 2021
E-commerce accounts for around 7% of GlaxoSmithKline (GSK) Consumer Healthcare’s total sales, according to chief executive officer Brian McNamara, but the business is “underdeveloped” compared to its industry peers in the vitamins, minerals and supplements (VMS) category.
GSK’s powerbrands record double-digit growth
Premium
2 August 2021
Six of GlaxoSmithKline (GSK) Consumer Healthcare’s nine powerbrands recorded double-digit sales growth in the second quarter of 2021, according to chief executive officer Brian McNamara.
GSK appoints McNamara to lead standalone business
23 July 2021
GlaxoSmithKline (GSK) has announced that Brian McNamara will remain chief executive officer of its Consumer Healthcare business following the planned separation in 2022.
GSK will evaluate Consumer Healthcare options
Premium
5 July 2021
GlaxoSmithKline (GSK ) will “evaluate any alternative options for Consumer Healthcare that may arise”, according to the company’s board, which says it is close to appointing a chief executive officer designate for the business ahead of the proposed separation.
Investor wants GSK to consider consumer sale
Premium
2 July 2021
Activist investor Elliott Investment Management is urging GlaxoSmithKline (GSK) to consider selling its Consumer Healthcare business rather than going ahead with the proposed separation.
GSK unveils separation plan for Consumer Healthcare
Premium
24 June 2021
GlaxoSmithKline (GSK) has confirmed plans to demerge its Consumer Healthcare business in mid 2022. The company says New Consumer Healthcare will have 20 brands each with sales in excess of GBP100 million (USD140 million).
PharmaSGP to acquire four OTC brands from GSK
Premium
17 June 2021
German consumer healthcare company PharmaSGP is acquiring a portfolio of four OTC brands in eight countries from GlaxoSmithKline (GSK) for around EUR80 million (USD95.5 million).
Divestments and COVID-19 drag down GSK’s sales
Premium
3 May 2021
GlaxoSmithKline (GSK) Consumer Healthcare reported a significant drop in sales during the first quarter of 2021 as divestments and the COVID-19 pandemic took their toll.
GSK explores paper bottles for three brands
Premium
25 March 2021
GlaxoSmithKline (GSK) Consumer Healthcare is exploring the use of paper bottles for its Centrum, Parodontax and Sensodyne brands as part of its sustainability programme.